Peripheral nerve function persons asymptomatic symptomatic HIV disease absence zidovudine neurotoxicity Nucleoside-induced neuropathy painful symmetric distal polyneuropathy neurotoxic potential zidovudine ZDV azidothymidine persons little human immunodeficiency virus HIV peripheral nerve function persons placebo-controlled studies ZDV early HIV disease Participants placebo ZDV doses mg median weeks time evaluation Neuropathic symptoms abnormalities motor sensory function present treatment groups reflexes ZDV group placebo group Quantitative sensory vibration abnormal participants absolute ZDV group low prevalence peripheral nerve abnormalities evidence ZDV neurotoxicity population 